Mumbai’s Haffkine Bio-Pharma targets 22.8 crore Covaxin vials a year Nation Mumbai’s Haffkine Bio-Pharma targets 22.8 crore Covaxin vials a year News Analysis India 3 years ago By PTI MUMBAI: After receiving permission to make Bharat Biotech’s COVID-19 vaccine Covaxin, Mumbai-based Haffkine Bio-Pharmaceutical on Friday said it would take least at one...Read More